BRCA2 and cancer: The need for supplementing PGS to BRCA2 PV status for more accurate risk assessment is evident by comparing the predicted probability from BRCA2‐only (open triangles) and BRCA2 + PGS (squares) with observed cancer prevalence (solid dots).